AGMI: Attention-Guided Multi-omics Integration for Drug Response Prediction with Graph Neural Networks
TL
TL;DR
A novel Attention-Guided Multi-omics Integration (AGMI) approach for DRP, which first constructs a Multiedge Graph for each cell line, and then aggregates multi-omics features to predict drug response using a novel structure, called Graph edge-aware Network (GeNet).
Abstract
Accurate drug response prediction (DRP) is a crucial yet challenging task in precision medicine. This paper presents a novel Attention-Guided Multi-omics Integration (AGMI) approach for DRP, which first constructs a Multiedge Graph (MeG) for each cell line, and then aggregates multi-omics features to predict drug response using a novel structure, called Graph edge-aware Network (GeNet). For the first time, our AGMI approach explores gene constraint based multi-omics integration for DRP with the whole-genome using GNNs. Empirical experiments on the CCLE and GDSC datasets show that our AGMI largely outperforms state-of-the-art DRP methods by 8.3%-34.2% on four metrics. Our data and code are available at https://github.com/yivan-WYYGDSG/AGMI.
References15 items
1
Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data
2
Drug Sensitivity Prediction From Cell Line-Based Pharmacogenomics Data: Guidelines for Developing Machine Learning Models
3
Graph Convolutional Network for Drug Response Prediction Using Gene Expression Data
4
Ensemble transfer learning for the prediction of anti-cancer drug response
5